Cargando…
Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update
There have been major advances in the treatment of HBV and HCV with anti-viral treatments, which is reducing the prevalence of fibrosis due to these viruses and obviating the need for anti-fibrotic therapies in these diseases. At the same time, however, the prevalence of non-alcoholic fatty liver di...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987269/ https://www.ncbi.nlm.nih.gov/pubmed/33776490 http://dx.doi.org/10.2147/JEP.S265286 |